FINRA Notice 21-03 highlights a critical intersection between anti-money laundering (AML) compliance and market integrity, particularly for firms active in underwriting, distributing, and trading low-priced or OTC securities.
These markets, often characterized by limited transparency and heightened volatility, present increased risk of fraud, manipulation, and regulatory exposure.
To remain compliant, firms must integrate AML-driven surveillance into every stage of their operations—from investment banking and market making to research and advisory functions.
Investment Banking: Managing Conflicts in Underwriting and Due Diligence
Investment banking divisions sit at the heart of capital formation—structuring, underwriting, and distributing securities. However, this central role also positions them at the crossroads of compliance and conflicts of interest.
Under FINRA Rule 2241, investment banking personnel are prohibited from influencing research coverage or analyst compensation, ensuring objectivity in market communications.
In the context of Notice 21-03, this expectation now extends to trade surveillance and AML integration.
Key Implications:
- AML-Integrated Due Diligence:
Bankers must embed AML checks into pitch books, roadshows, and term sheets—identifying red flags early in the deal lifecycle. This is especially vital for low-priced OTC offerings, where issuer transparency is limited.
- Surveillance for Prearranged Trading:
Without coordinated oversight, firms risk facilitating prearranged or manipulative trades, such as post-IPO “pump-and-dump” activity.Integrating compliance review during syndication and distribution reduces exposure to Rule 3110 supervisory failures.
- Leveraging OTC Markets Compliance Feeds:
When quoting or distributing OTC securities, investment bankers should rely on OTC Markets Group’s data feeds that flag delinquent filers or shell companies.
This ensures that block trades or microcap transactions undergo AML scrutiny for momentum ignition—a tactic where artificial volume attracts unsuspecting retail investors.
Ultimately, AML-aligned underwriting ensures not only regulatory protection but also strengthens market reputation and investor confidence.
Market Making: Surveillance in High-Frequency, Low-Transparency Environments
Market makers play a vital role in maintaining liquidity—but in OTC and low-priced securities, that role comes with significant exposure to manipulation risk.
Tactics such as spoofing, layering, and marking the open or close remain major red flags under Notice 21-03.
Key Implications:
- Embedded AML Protocols in Trading Systems:
Market makers must integrate AML screening within quoting and execution platforms, identifying non-bona fide orders that may indicate money laundering or manipulative intent.
- Real-Time Surveillance Beyond Blotter Reviews:
Traditional end-of-day trade reviews are insufficient.
Real-time monitoring of order flow, cancellations, and geographic patterns—especially within omnibus accounts from foreign financial institutions (FFIs)—is essential for detecting hidden risks.
- Algorithmic Integration:
Connecting market-making algorithms to AML dashboards allows automatic escalation of suspicious patterns to compliance teams for SAR (Suspicious Activity Report) evaluation.
This integrated framework ensures compliance with Rule 5210 (Publication of Manipulative Information) and mitigates regulatory exposure during FINRA and SEC examinations.
Research Departments: Balancing Independence with Risk Awareness
Research departments face a dual challenge: maintaining independence while staying vigilant to AML and market manipulation indicators.
While Rule 2241 enforces strict firewalls from investment banking, Notice 21-03 introduces new expectations for risk-informed research practices.
Key Implications:
- AML Data in Coverage Reports:
Analysts covering low-priced or thinly traded securities should incorporate surveillance and issuer compliance data—highlighting potential manipulation indicators or regulatory filings.
- Cross-Referencing Red Flags:
Research teams must verify unusual volume spikes or price surges against AML alerts to avoid inadvertently amplifying fraudulent narratives.
- Firm-Wide AML Coordination:
Multi-service firms should ensure research participation in AML testing and training, improving cross-departmental awareness of manipulation trends tied to covered securities.
- Enhanced Disclosures:
Reports should clearly state if the firm is a market maker in the security, ensuring compliance with Rule 2010’s principles of just and equitable trade conduct.
When analysts integrate AML insights without compromising independence, research becomes a risk-aware, trust-building function, not a liability.
Conclusion: Cohesion Is Compliance
The message from FINRA Notice 21-03 is clear:
AML compliance can no longer operate in isolation.
From underwriting and trading to research and distribution, each department plays a role in identifying, preventing, and reporting manipulative activity.
Firms that align their systems—linking AML analytics, market surveillance, and due diligence workflows—not only reduce regulatory risk but also position themselves as leaders in integrity-driven capital markets.
MCG Comply’s team can help your firm conduct the right assessment and assist proactively improve your AML surveillance, reach out to info@mcgcomply.com
